Udg Healthcare (LON:UDG) Upgraded by Berenberg Bank to “Buy”

Berenberg Bank upgraded shares of Udg Healthcare (LON:UDG) to a buy rating in a research report released on Monday morning, Digital Look reports. The brokerage currently has GBX 920 ($12.10) price objective on the stock, up from their prior price objective of GBX 850 ($11.18).

UDG has been the topic of a number of other reports. Peel Hunt reissued a buy rating on shares of Udg Healthcare in a report on Friday, January 10th. Liberum Capital reaffirmed a buy rating on shares of Udg Healthcare in a report on Friday, January 10th. Finally, Barclays reaffirmed an overweight rating on shares of Udg Healthcare in a report on Tuesday, January 7th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of Buy and an average price target of GBX 902.33 ($11.87).

Shares of UDG stock opened at GBX 822 ($10.81) on Monday. The stock’s 50-day simple moving average is GBX 802.03 and its 200-day simple moving average is GBX 780.81. The company has a debt-to-equity ratio of 26.65, a quick ratio of 1.43 and a current ratio of 1.59. The firm has a market capitalization of $2.06 billion and a PE ratio of 35.90. Udg Healthcare has a fifty-two week low of GBX 545 ($7.17) and a fifty-two week high of GBX 846 ($11.13).

The business also recently announced a dividend, which will be paid on Wednesday, February 5th. Investors of record on Thursday, January 9th will be issued a dividend of $0.12 per share. This represents a yield of 1.28%. This is a positive change from Udg Healthcare’s previous dividend of $0.04. The ex-dividend date of this dividend is Thursday, January 9th. Udg Healthcare’s dividend payout ratio (DPR) is 0.57%.

Udg Healthcare Company Profile

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.

See Also: Stock Symbol

Analyst Recommendations for Udg Healthcare (LON:UDG)

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.